Achilles Therapeutics: cNeT (clonal neoantigen) process builds on TILs, combined with ability to identify pt-specific clonal neoantigens and generate personalized T-cell therapies. Sep19 GBP100 million Series B w/ RA, Syncona, Forbion, Invus, Perceptive + Redmile.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Immuno-Oncology, Immunotherapy, Oncology
Industry
Biotechnology
Listing
Europe, Private
Website:
Address:
Stevenage Bioscience Catalyst, Gunnels Wood Road
Stevenage, Herefordshire SG12FX
United Kingdom

Company Participants at Solebury Trout Management Access SF 2020

  • Beverley Carr, PhD, Chief Business Officer
  • Edwin Moses, PhD, Chairman of the Board
  • Iraj Ali, PhD, CEO
  • Michael Giordano, Director

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Fall Private Company Showcase 2020

VIRTUAL, October 15, 2020